Who owns Haya Therapeutics?

Haya Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Haya Therapeutics?

Sofinnova Partners acquired Haya Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Haya Therapeutics

Haya Therapeutics

Biotech·

Switzerland·Active·5yr hold

Haya Therapeutics is a healthcare / biotech company, headquartered in Switzerland.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQSwitzerland

SectorHealthcare / Biotech

Swiss precision medicine company developing programmable therapeutics targeting regulatory RNAs from the dark genome.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings